AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer

AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer

Abstract Triple-negative breast cancer (TNBC) is an aggressive subset of breast carcinomas that lack expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2). Unlike other breast cancer subtypes, targeted therapy is presently unavailable f...

Full description

Bibliographic Details
Main Authors: Wei Cao, Jieqing Li, Qiongyu Hao, Jaydutt V Vadgama, Yong Wu
Format: Article
Language:English
Published: BMC 2019-02-01
Series:Breast Cancer Research
Subjects:
Triple-negative breast cancer
AMP-activated protein kinase
Chemotherapy
Targeted treatment
Online Access:http://link.springer.com/article/10.1186/s13058-019-1107-2

Internet

http://link.springer.com/article/10.1186/s13058-019-1107-2

Similar Items